Related Experiment Video

Updated: Jun 26, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

921

JAM3 promotes cervical cancer metastasis by activating the HIF-1α/VEGFA pathway

Jiali Peng1, Yao Chen2, Aijun Yin3

  • 1Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.

BMC Women'S Health
|May 17, 2024
PubMed

Insights

Junctional adhesion molecule 3 (JAM3) promotes cervical cancer metastasis by activating the HIF-1α/VEGFA pathway. This finding suggests JAM3 could be a new therapeutic target for cervical cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Cervical cancer is a leading cause of cancer mortality in women globally.
  • Tumor metastasis significantly worsens prognosis, necessitating research into its mechanisms and therapies.
  • The role of Junctional Adhesion Molecule 3 (JAM3) in cervical cancer progression requires further elucidation.

Purpose of the Study:

  • To investigate the function and mechanism of JAM3 in cervical cancer metastasis.
  • To determine if JAM3 expression correlates with lymph node metastasis.
  • To explore JAM3's potential as a therapeutic target.

Main Methods:

  • Analysis of JAM3 expression in cervical cancer patient samples.
  • In vitro and in vivo studies to assess the impact of JAM3 on cell metastasis.
  • Investigation of JAM3's effect on epithelial-mesenchymal transition (EMT).
  • Examination of the HIF-1α/VEGFA pathway activation by JAM3.

Main Results:

  • High JAM3 expression was observed in cervical cancer patients with lymph node metastasis.
  • Overexpression of JAM3 enhanced cervical cancer cell migration and invasion in vitro and in vivo.
  • JAM3 induced epithelial-mesenchymal transition (EMT) in cancer cells.
  • Silencing JAM3 reduced cancer cell migration and invasion.
  • JAM3 activation of the HIF-1α/VEGFA pathway was confirmed.

Conclusions:

  • JAM3 significantly promotes cervical cancer cell migration and invasion.
  • The mechanism involves the activation of the HIF-1α/VEGFA pathway.
  • JAM3 represents a potential biomarker and therapeutic target for cervical cancer.
Keywords:
Cervical cancerHIF-1α/VEGFA pathwayJAM3Metastasis

More Related Videos

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

2.6K
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

10.8K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K